ASP2535 is an inhibitor of the type 1 glycine transporter.

[1] It could potentially be used in treatment of Alzheimer's disease and schizophrenia.

ASP2535 has been investigated for the treatment of Alzheimer's disease and schizophrenia, it is able to inhibit the memory deficit induced by scopolamine, an anticholinergic agent.

This pharmacology-related article is a stub.

You can help Wikipedia by expanding it.This article about a biochemical receptor is a stub.